Exchange: NASDAQ·Updated 04:34 PM EST
TLX logo

TLX Telix Pharmaceuticals Limited American Depositary Shares

$8.39
$0.34
(3.90%)
Today
Closed $8.37
$0.02
(0.24%)
After Hours
EarningsFeb 17
Mkt Cap$2.96B
Vol269,412.00

About TLX

Telix Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development and commercialization of several clinical-stage oncology assets. The firm operates through the following segments: Therapeutics (Tx), Precision Medicine (Px), and Telix Manufacturing Solutions (TMS). The Tx segment focuses on development of targeted radionuclide therapies for urologic and neurologic oncology, and other solid tumors. The Px segment includes provision of diagnostic imaging solutions to market and expanding into new geographies and indications. The TMS segment comprises of costs to operate the firm's facilities and assets. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East and Africa. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in North Melbourne, Australia.
45

Neutral Sentiment

How do you feel about TLX?

Mani86
$TLX Company with a billion dollar revenue selling at approx 3 times price to sales. Big buying opportunity if some can hold for a year, expect an easy double from here if not more.
1
Rayvio_News_Filter
$TLX 🏥 Corxel Pharmaceuticals Limited presented full Phase 2 results for CX11 in adults with overweight and obesity, with all four dose regimens delivering 9.3% to 11.5% mean weight loss at 36 weeks versus 3.1% for placebo and no hepatic safety signal.

Advertisement|Remove ads.